δ-Catenin Is Genetically and Biologically Associated with Cortical Cataract and Future Alzheimer-Related Structural and Functional Brain Changes

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Jun, Gyungah ^a,b   Moncaster, Juliet A ^b   Koutras, Carolina ^c   Seshadri, Sudha ^a,b   Buros, Jacqueline ^a   McKee, Ann C ^a,b,d   Levesque, Georges ^e   Wolf, Philip A ^a,b   St George Hyslop, Peter ^c,f   Goldstein, Lee E ^a,b   Farrer, Lindsay A ^a,b  

^a BOSTON UNIVERSITY   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e LAVAL UNIVERSITY   (Canada)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; BETA CATENIN; CATENIN; DELTA CATENIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMYLOID PRECURSOR PROTEIN GENE; ARTICLE; BRAIN SIZE; CONTROLLED STUDY; CTNND2 GENE; DELTA CATENIN GENE; DISEASE ASSOCIATION; EMBRYO; GENE; GENE EXPRESSION; GENETIC VARIABILITY; HERITABILITY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MUTATOR GENE; NERVE CELL CULTURE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; SENILE CATARACT; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BASE PAIRING; BRAIN; CASE-CONTROL STUDIES; CATARACT; CATENINS; COMPUTATIONAL BIOLOGY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HEK293 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; LATERAL VENTRICLES; LENS, CRYSTALLINE; MALE; MUTATION; NEUROPSYCHOLOGICAL TESTS; ORGAN SIZE; POLYMORPHISM, SINGLE NUCLEOTIDE;

THEILOVIRUS;

EID: 84866274928     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043728     Document Type: Article

References (59)

1. 2011 Alzheimer's Disease Facts and Figures. Available: http://www.alz.org/alzheimers_disease_facts_and_figures.asp. Accessed 2012 Jul 29.
2. National Eye Institute. National Plan for Eye and Vision Research: Lens and Cataract Program. [September 11, 2009]. Available: http://www.nei.nih.gov/strategicplanning/np_lens.asp. Accessed 2012 Jul 29.
3. Farrer LA, (1997) Genetics and the dementia patient. Neurologist 3: 13-30.
4. Sanfilippo PG, Hewitt AW, Hammond CJ, Mackey DA, (2010) The heritability of ocular traits. Surv Ophthalmol 55: 561-583.
5. Sherva R, Farrer LA, (2011) Power and pitfalls of the genome wide association study approach to identify genes for Alzheimer disease. Cur Psych Rep 13: 138-146.
6. Farrer LA, Cupples LA, Haines JL, Hyman BT, Kukull WA, et al. (1997) Effects of age, gender and ethnicity on the association of apolipoprotein E genotype and Alzheimer disease. JAMA 278: 1349-1356.
7. Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, et al. (2011) Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet 43: 429-435.
8. Naj AC, Jun G, Beecham GW, Wang L-S, Vardarajan B-N, et al. (2011) Genome-wide association study of late-onset Alzheimer disease identifies disease associated variants in MS4A4/MS4A6E, CD2AP, CD33, and EPHA1. Nat Genet 43: 436-441.
9. Shiels A, Bennett TM, Hejtmancik JF, (2010) Cat-Map: putting cataract on the map. Mol Vis 16: 2007-2015.
10. Goldstein LE, Muffat JA, Cherny RA, Moir RD, Ericsson MH, et al. (2003) Cytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease. Lancet 361: 1258-1265.
11. Moncaster JA, Pineda R, Moir RD, Lu S, Burton MA, et al. (2010) Alzheimer's disease amyloid-beta links lens and brain pathology in Down syndrome. PLoS One 5 (5):: e10659.
12. Moncaster JA, Moir RD, Mocofanescu A, Fu L, Lu S, et al. Noninvasive ocular detection of Aβ lens pathology before cerebral plaque formation in Alzheimer disease transgenic mice. Submitted.
13. Melov S, Wolf N, Strozyk D, Doctrow SR, Bush AI, (2005) Mice transgenic for Alzheimer disease beta-amyloid develop lens cataracts that are rescued by antioxidant treatment. Free Radic Biol Med 38: 258-261.
14. Frederikse PH, Ren XO, (2002) Lens defects and age-related fiber cell degeneration in a mouse model of increased AbetaPP gene dosage in Down syndrome. Am J Pathol 161: 1985-1990.
15. Frederikse PH, Zigler JS Jr, (1998) Presenilin expression in the ocular lens. Curr Eye Res 17: 947-952.
16. Frederikse PH, (2000) Amyloid-like protein structure in mammalian ocular lenses. Curr Eye Res 20: 462-468.
17. Dhaenens CM, Van Brussel E, Schraen-Maschke S, Pasquier F, Delacourte A, et al. (2004) Association study of three polymorphisms of kinesin light-chain 1 gene with Alzheimer's disease. Neurosci Lett 368: 290-292.
18. Andersson ME, Zetterberg M, Tasa G, Seibt-Palmér M, Juronen E, et al. (2007) Variability in the kinesin light chain 1 gene may influence risk of age-related cataract. Mol Vis 13: 993-996.
19. von Otter M, Landgren S, Nilsson S, Lundvall C, Minthon L, et al. (2010) Kinesin light chain 1 gene haplotypes in three conformational diseases. Neuromolecular Med 12: 229-236.
20. Jun G, Guo H, Klein BE, Klein R, Wang JJ, et al. (2009) EPHA2 is associated with age-related cortical cataract in mice and humans. PLoS Genet 5 (7):: e1000584.
21. Seshadri S, Fitzpatrick A, Ikram MA, DeStefano AL, Gudnason V, et al. (2010) Genome-wide association study of Alzheimer disease. JAMA 303: 1832-1840.
22. Potkin SG, Guffanti G, Lakatos A, Turner JA, Kruggel F, et al. (2009) Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease. PLoS One 4 (8):: e6501.
23. Cooper MA, Crockett DP, Nowakowski RS, Gale NW, Zhou R, (2009) Distribution of EphA5 receptor protein in the developing and adult mouse nervous system. J Comp Neurol 514: 310-328.
24. Dawber TR, Kannel WB, (1966) The Framingham study. An epidemiological approach to coronary heart disease. Circulation 34: 553-555.
25. Feinleib M, Kannel WB, Garrison RJ, McNamara PM, Castelli WP, (1975) The Framingham Offspring Study. Design and preliminary data. Prev Med 4: 518-525.
26. Hiller R, Sperduto RD, Reed GF, D'Agostino RB, Wilson PW, (2003) Serum lipids and age-related lens opacities: a longitudinal investigation: the Framingham Studies. Ophthalmology 110: 578-583.
27. Taylor HR, West SK, (1989) The clinical grading of lens opacities. Aust N Z J Ophthalmol 17: 81-86.
28. West SK, Rosenthal F, Newland HS, Taylor HR, (1988) Use of photographic techniques to grade nuclear cataracts. Invest Ophthalmol Vis Sci 29: 73-77.
29. DeCarli C, Massaro J, Harvey D, Hald J, Tullberg M, et al. (2005) Measures of brain morphology and infarction in the framingham heart study: establishing what is normal. Neurobiol Aging 26: 491-510.
30. Farmer ME, White LR, Kittner SJ, Kaplan E, Moes E, et al. (1987) Neuropsychological test performance in Framingham: a descriptive study. Psychol Rep 60: 1023-1040.
31. Au R, Seshadri S, Wolf PA, Elias M, Elias P, et al. (2004) New norms for a new generation: cognitive performance in the framingham offspring cohort. Exp Aging Res 30: 333-358.
32. Janssens MJJ, (1979) Co-heritability: its relation to correlated response, linkage and pleiotropy in cases of polygenic inheritance. Euphytica 28: 601-608.
33. Elston RC, Gray-McGuire C, (2004) A review of the 'Statistical Analysis for Genetic Epidemiology' (S.A.G.E.) software package. Hum Genomics 1: 456-459.
34. Keen KJ, Elston RC, (2003) Robust asymptotic sampling theory for correlations in pedigrees. Stat Med 22: 3229-3247.
35. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575.
36. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, et al. (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38: 904-909.
37. Wang T, Elston RC, (2005) Two-level Haseman-Elston regression for general pedigree data analysis. Genet Epidemiol 29: 12-22.
38. Wang T, Elston RC, (2007) Regression-based multivariate linkage analysis with an application to blood pressure and body mass index. Annals of Hum Genet 71: 96-106.
39. Choi S-H, Liu C, Dupuis J, Logue ML, Jun G, (2011) Using linkage analysis of large pedigrees to guide association analyses. BMC Proc 5 Suppl 9: S79.
40. Li Y, Willer CJ, Ding J, Scheet P, Abecasis GR, (2009) MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol 34: 816-834.
41. So HC, Gui AH, Cherny SS, Sham PC, (2011) Evaluating the heritability explained by known susceptibility variants: a survey of ten complex diseases. Genet Epidemiol 35: 310-317.
42. So HC, Li M, Sham PC, (2011) Uncovering the total heritability explained by all true susceptibility variants in a genome-wide association study. Genet Epidemiol 35: 447-456.
43. Jack CR Jr, Slomkowski M, Gracon S, Hoover TM, Felmlee JP, et al. (2003) MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD. Neurology 60: 253-260.
44. Jacobs DM, Sano M, Dooneief G, Marder K, Bell KL, et al. (1995) Neuropsychological detection and characterization of preclinical Alzheimer's disease. Neurology 45: 957-962.
45. Elias MF, Beiser A, Wolf PA, Au R, White RF, et al. (2000) The preclinical phase of Alzheimer disease: a 22-year prospective study of the Framingham cohort. Arch Neurol 57: 808-813.
46. Blacker D, Lee H, Muzikansky A, Martin EC, Tanzi R, et al. (2007) Neuropsychological measures in normal individuals that predict subsequent cognitive decline. Arch Neurol 64: 862-871.
47. Duparc RH, Boutemmine D, Champagne MP, Tétreault N, Bernier G, (2006) Pax6 is required for delta-catenin/neurojugin expression during retinal, cerebellar and cortical development in mice. Dev Biol 300: 647-655.
48. Zhou J, Liyanage U, Medina M, Ho C, Simmons AD, et al. (1997) Presenilin 1 interaction in the brain with a novel member of the Armadillo family. Neuroreport 8: 1489-1494.
49. Kouchi Z, Barthet G, Serban G, Georgakopoulos A, Shioi J, et al. (2009) p120 catenin recruits cadherins to gamma-secretase and inhibits production of Abeta peptide. J Biol Chem 284: 1954-1961.
50. Hatzfeld M, Nachtsheim C, (1996) Cloning and characterization of a new armadillo family member, p0071, associated with the junctional plaque: evidence for a subfamily of closely related proteins. J Cell Sci 1109 (Pt 11):: 2767-2778.
51. Stahl B, Diehlmann A, Südhof TC, (1999) Direct interaction of Alzheimer's disease-related presenilin 1 with armadillo protein p0071. J Biol Chem 274: 9141-9148.
52. Liauw J, Nguyen V, Huang J, St George-Hyslop P, Rozmahel R, (2002) Differential display analysis of presenilin 1-deficient mouse brains. Brain Res Mol Brain Res 109: 56-62.
53. Israely I, Costa RM, Xie CW, Silva AJ, Kosik KS, et al. (2004) Deletion of the neuron-specific protein delta-catenin leads to severe cognitive and synaptic dysfunction. Curr Biol 14: 1657-1663.
54. Matter C, Pribadi M, Liu X, Trachtenberg JT, (2009) Delta-catenin is required for the maintenance of neural structure and function in mature cortex in vivo. Neuron 64: 320-327.
55. Restituito S, Khatri L, Ninan I, Mathews PM, Liu X, et al. (2011) Synaptic autoregulation by metalloproteases and γ-secretase. J Neurosci 31: 12083-12093.
56. Georgakopoulos A, Marambaud P, Efthimiopoulos S, Shioi J, Cui W, et al. (1999) Presenilin-1 forms complexes with the cadherin/catenin cell-cell adhesion system and is recruited to intercellular and synaptic contacts. Mol Cell 4: 893-902.
57. Levesque G, Yu G, Nishimura M, Zhang M, Levesque L, et al. (1999) Presenilins interact with armadillo proteins including neural-specific plakophilin-related protein and β-catenin. J Neurochem 72: 999-1008.
58. De Jager PL, Shulman JM, Chibnik LB, Keenan BT, Raj T, et al. (2011) A genome-wide scan for common variants affecting rate of age-related cognitive decline. Neurobiol Aging In press.
59. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, et al. (2010) A method and server for predicting damaging missense mutations. Nat Methods 7: 248-249.